Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese

International Journal of Gastrointestinal Cancer

Volumn 34, Issue 1, 2003, Pages 19-26

  Heneghan, Michael A ^a,b   Johnson, Philip J ^c   Clare, Michael ^a   Ho, Stephen ^c   Harrison, Phillip M ^a   Donaldson, Peter T ^a,d  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Gene polymorphism; Hepatocellular carcinoma; Immunogenetics

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ALLELE; ANTIGEN SPECIFICITY; ARTICLE; CHINESE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK PATIENT; HONG KONG; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHINA; CYTOKINES; EUROPE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HONG KONG; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 3242713143     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bosch FX, Munoz N. Hepatocellular Carcinoma in the world: epidemiologic questions. In Tabor E, DiBisceglie AM, Purcell RH, eds. Etiology, Pathology and Treatment of Hepatocellular Carcinoma in North America. Houston: Gulf Publishing Co., 1991, pp. 35-54.
2. Johnson PJ. The epidemiology of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1996;8:845-849.
3. Hsu IC, Metcalf RA, Sun T, et al. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427-428.
4. Aguilar F, Harris CC, Sun T, et al. Geographic variation of p53 mutational profile in nonmalignant human liver. Science 1994;264:1317-1319.
5. Lunn RM, Zhang YJ, Wang LY, et al. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res 1997;57: 3471-3477.
6. Mansfield JC, Holden H, Tarlow JK, et al. Novel genetic association between ulcerative colitis and the antiinflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994;106:637-642.
7. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-2147.
8. Pociot F, Molvig J, Wogensen L, et al. A Taq1 polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992;22:396-402.
9. Tarlow JK, Blakemore AI, Lennard A, et al. Polymorphism in the human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993;91:403-404.
10. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1RA and IL-1B genes. Eur J Immunol 1998;28:2598-2602.
11. Fanning G, Bunce M, Black CM, et al. Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin α. Tissue Antigens 1997;50:23-31.
12. Wilson AG, Di Giovine FS, Blakemore AIF, et al. Single base change in the human tumor necrosisfactor (TNF-α) gene detectable by Nco1 restriction of PCR product. Hum Mol Genet 1992;1:353.
13. Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in human tumor necrosisfactor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94:3195-3199.
14. Westendorp RGJ, Langermans JAM, Huizinga TWJ, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349:170-173.
15. Kim JM, Brannan CL, Copeland NG, et al. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 1992;148:3618-3623.
16. Turner DM, Williams DM, Sankaran D, et al. Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 promoter. Eur J Immunogenet 1997;24:1-8.
17. Thompson K, Maltby J, Fallowfield J, et al. Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis. Hepatology 1998;28: 1597-606.
18. Louis H, Van Laethem JL, Wu W, et al. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 1998;28:1607-1615.
19. Bioque G, Crusius JBA, Koutroubakis I, et al. Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 1995;102:379-383.
20. McGuire W, Hill AVS, Allsopp CEM, et al. Variation in the TNF-a promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-511.
21. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenet 1994;39:150-154.
22. Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994; 43:18-27.
23. Cookson S, Constantini PK, Clare M, et al. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 1999;30:851-856.
24. Perrier S, Coussediere C, Dubost JJ, et al. IL-1 receptor antangonist (IL-1RA) gene polymorphism in Sjogren's syndrome and rheumatoid arthritis. Clin Immunol Immunopathol 1998;87:309-313.
25. Wang Y, Kato N, Hoshida Y, et al. Interleukin-1 gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 2003;37,65-71.
26. Moore KW, O'Garra A, De Waal Malefyt R, et al. Interleukin-10. Annu Rev Immunol 1993;11:165-190.
27. Edwards-Smith CJ, Jonsson JR, Purdie DM, et al. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 1999;30:526-530.
28. Romero R, Lavine JE. Cytokine inhibition of the hepatitis B virus core promoter. Hepatology 1996;23:17-23.
29. Guidotti LG, Borrow P, Hobbs MV, et al. Intracellular inactivation of the hepatitis B virus by cytotoxic B lymphocytes. Immunity 1996;4:25-36.